Table 3.
Tissue | Model | Effect | Reference |
---|---|---|---|
Protective Role of ATF6 Signalling | |||
Heart | Mouse model of myocardial ischemia/reperfusion damage KO of ATF6 in mice |
When compared to wild-type tissue, ATF6 KO mouse cardiac tissue exhibited increased damage upon ischemia/reperfusion. Mechanistically, ATF6 upregulates oxidative stress genes, such as catalase, to exert cardioprotective effects in this context | [49] |
Kidney | Tunicamycin-induced cytotoxicity in rat-derived glomerular epithelial cells (GECs) | Calcium-independent phospholipase A2γ (iPLA2γ) is protective against GEC injury. ATF6 contributes to iPLA2γ-mediated cytoprotection | [50] |
Brain | Short-form ATF6 KI in forebrain neurons of mice (tamoxifen-inducible activation) Experimental model of stroke induced by middle cerebral artery occlusion |
Forced activation of ATF6 reduced infarct volume and improved functional outcome following 24 h post-model induction | [51] |
R6/2 mouse model of Huntington’s disease | Derepression of ATF6 was associated with early neuroprotection in this model of Huntington’s disease | [52] | |
Kainate-induced neurotoxicity in hippocampi of mice ATF6α KO |
Kainate induced pronounced neuronal death in hippocampal CA3 region of ATF6α-KO mice. Hence, ATF6α protects against kainate-induced neurotoxicity in mice | [53] | |
Pancreas/Liver | Diet-induced obese mice KOt of ATF6α |
ATF6α protects pancreatic β-cells from endoplasmic reticulum stress | [55] |
Zebrafish model of endoplasmic reticulum stress and fatty liver disease Depletion of active ATF6 through mutation in site-1 protease gene (mbtps1) or atf6 morpholino injection |
ATF6 protects against hepatic steatosis following tunicamycin-induced acute endoplasmic reticulum stress | [57] | |
Pathological Role of ATF6 Signalling | |||
Liver | OE of activated form of ATF6α in human hepatocellular carcinoma cell line (HLF) | ATF6α maylead to hepatocarcinogenesis by directly and indirectly regulating a broad range of genes associated with transformation |
[46] |
Zebrafish model of endoplasmic reticulum stress and fatty liver disease; Depletion of active ATF6 through mutation in site-1 protease gene (mbtps1) or atf6 morpholino injection | ATF6 ➔ hepatic steatosis resulting from chronic endoplasmic reticulum stress | [57] | |
Squamous Epithelium | Quiescent human squamous carcinoma cells (D-HEp3 cells) KD of ATF6α expression in D-Hep3 cells using chick chorioallantoic membrane and nude mice for xenograft studies |
ATF6α ➔ dormant cell survival, adaptation of dormant cells to chemotherapy, nutritional stress and the in vivo microenvironment ATF6α-Rheb-mTOR signalling ➔ survival and adaptation of carcinoma cells |
[47] |
Pancreas | Diet-induced obese mice KO of ATF6α |
ATF6α ➔ development of hyperlipidaemia and insulin resistance in mouse model of diabetes | [55] |
Otsuka Long Evans Tokushima Fatty rat model of type II diabetes | ↑ ATF6 in pancreatic islets in diseased rats; ATF6 ➔ ↓insulin levels |
[56] |
Key: ATF6 activating transcription factor 6, GEC glomerular epithelial cell, iPLA2γ calcium-independent phospholipase A2γ, KD knockdown, KI knockin, KO knockout